Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Diagnostic and prognostic value of serum L1-cell adhesion molecule in esophageal squamous cell carcinoma.

Xu YW, Hong CQ, Wu ZY, Peng YH, Ran LQ, Yang SH, Huang BS, Liang XY, Chen HL, Wu JY, Xu XE, Deng JW, Zou HY, Fang WK, Li EM, Xu LY, Xie JJ.

Clin Res Hepatol Gastroenterol. 2018 Dec;42(6):597-603. doi: 10.1016/j.clinre.2018.08.010. Epub 2018 Sep 13.

PMID:
30219694
2.

Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.

Xu YW, Peng YH, Ran LQ, Zhai TT, Guo HP, Qiu SQ, Chen HL, Wu ZY, Li EM, Xie JJ.

Clin Transl Oncol. 2017 Jul;19(7):898-906. doi: 10.1007/s12094-017-1623-4. Epub 2017 Feb 8.

PMID:
28181176
3.

L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.

Guo JC, Xie YM, Ran LQ, Cao HH, Sun C, Wu JY, Wu ZY, Liao LD, Zhao WJ, Fang WK, Li EM, Xu LY, Schachner M, Xie JJ.

J Mol Med (Berl). 2017 Dec;95(12):1355-1368. doi: 10.1007/s00109-017-1595-4. Epub 2017 Sep 22.

PMID:
28939985
4.

MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.

Guan S, Wang C, Chen X, Liu B, Tan B, Liu F, Wang D, Han L, Wang L, Huang X, Wang J, Yao B, Shi J, Chen P, Nesa EU, Song Q, Cheng Y.

Tumour Biol. 2016 Apr;37(4):4383-91. doi: 10.1007/s13277-015-4271-8. Epub 2015 Oct 24.

PMID:
26499784
5.

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.

Dong J, Zeng BH, Xu LH, Wang JY, Li MZ, Zeng MS, Liu WL.

J Transl Med. 2010 Sep 3;8:81. doi: 10.1186/1479-5876-8-81.

6.

Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.

Tang X, Fan Z, Wang Y, Ji G, Wang M, Lin J, Huang S.

Dis Esophagus. 2016 Apr;29(3):207-14. doi: 10.1111/dote.12289. Epub 2014 Oct 6.

PMID:
25287007
7.

The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma.

Huang X, Hong C, Peng Y, Yang S, Huang L, Liu C, Chen L, Chu L, Xu L, Xu Y.

J Cancer. 2019 Jun 2;10(12):2687-2693. doi: 10.7150/jca.32393. eCollection 2019.

8.

Elevated levels of serum nidogen-2 in esophageal squamous cell carcinoma.

Chai AWY, Cheung AKL, Dai W, Ko JMY, Lee NPY, Chan KT, Law SY, Lung ML.

Cancer Biomark. 2018 Feb 14;21(3):583-590. doi: 10.3233/CBM-170484.

PMID:
29278876
9.

Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.

Peng YH, Xu YW, Guo H, Huang LS, Tan HZ, Hong CQ, Li SS, Xu LY, Li EM.

Cancer Med. 2016 Jul;5(7):1388-96. doi: 10.1002/cam4.702. Epub 2016 Mar 14.

10.

Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.

Chen WX, Hong XB, Hong CQ, Liu M, Li L, Huang LS, Xu LY, Xu YW, Peng YH, Li EM.

Clin Res Hepatol Gastroenterol. 2017 Jun;41(3):327-332. doi: 10.1016/j.clinre.2016.10.011. Epub 2016 Dec 9.

PMID:
27956255
11.

Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.

Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ, Cao XF.

Mol Cancer. 2015 Jan 21;14:3. doi: 10.1186/1476-4598-14-3.

12.

Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.

Li J, Li M, Gao F, Ge X.

Cancer Biomark. 2017;18(1):11-17. doi: 10.3233/CBM-160667.

PMID:
27802201
13.

Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.

Wang C, Guan S, Liu F, Chen X, Han L, Wang D, Nesa EU, Wang X, Bao C, Wang N, Cheng Y.

Br J Cancer. 2016 Feb 2;114(3):290-7. doi: 10.1038/bjc.2015.463. Epub 2016 Jan 21.

14.

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.

Wang W, He X, Zheng Z, Ma X, Hu X, Wu D, Wang M.

Mol Cancer. 2017 Apr 4;16(1):75. doi: 10.1186/s12943-017-0643-6.

15.

[Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].

Chen J, Chen M.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Oct 28;43(10):1048-1053. doi: 10.11817/j.issn.1672-7347.2018.10.002. Chinese.

16.

Clinical significance of angiopoietin-like protein 4 expression in tissue and serum of esophageal squamous cell carcinoma patients.

Yi J, Pan BZ, Xiong L, Song HZ.

Med Oncol. 2013;30(3):680. doi: 10.1007/s12032-013-0680-y. Epub 2013 Aug 8.

17.

Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.

Wu C, Wang C, Guan X, Liu Y, Li D, Zhou X, Zhang Y, Chen X, Wang J, Zen K, Zhang CY, Zhang C.

PLoS One. 2014 Mar 20;9(3):e92292. doi: 10.1371/journal.pone.0092292. eCollection 2014.

18.

Identification and validation of circulating exosomes-based liquid biopsy for esophageal cancer.

Zhao A, Guo L, Xu J, Zheng L, Guo Z, Ling Z, Wang L, Mao W.

Cancer Med. 2019 Jul;8(7):3566-3574. doi: 10.1002/cam4.2224. Epub 2019 May 17.

19.

Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.

Cui Y, Xue Y, Dong S, Zhang P.

J Int Med Res. 2017 Aug;45(4):1310-1317. doi: 10.1177/0300060517709370. Epub 2017 Jun 6.

20.

Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.

Sedighi M, Aledavood SA, Abbaszadegan M, Memar B, Montazer M, Rajabian M, Gholamin M.

Asian Pac J Cancer Prev. 2016;17(6):2781-5.

Supplemental Content

Support Center